 Ryan Allen
Concepts (112)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 4 | 2025 | 360 | 1.150 |
Why?
| | RNA, Small Untranslated | 5 | 2025 | 9 | 0.890 |
Why?
| | Toll-Like Receptor 8 | 1 | 2022 | 3 | 0.790 |
Why?
| | MicroRNAs | 5 | 2020 | 385 | 0.610 |
Why?
| | Cholesterol | 2 | 2014 | 160 | 0.440 |
Why?
| | Ubiquinone | 1 | 2014 | 14 | 0.440 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2014 | 35 | 0.440 |
Why?
| | Lipoproteins | 1 | 2014 | 41 | 0.440 |
Why?
| | Transcription Factor AP-1 | 1 | 2014 | 62 | 0.440 |
Why?
| | Lipoproteins, HDL | 3 | 2022 | 16 | 0.430 |
Why?
| | Atherosclerosis | 2 | 2022 | 225 | 0.400 |
Why?
| | Arthritis, Rheumatoid | 2 | 2020 | 116 | 0.300 |
Why?
| | Plasminogen | 1 | 2025 | 3 | 0.240 |
Why?
| | Fibrinolysis | 1 | 2025 | 6 | 0.240 |
Why?
| | Ribonucleoproteins | 1 | 2025 | 24 | 0.240 |
Why?
| | Mice | 6 | 2025 | 5877 | 0.210 |
Why?
| | Animals | 8 | 2025 | 13332 | 0.200 |
Why?
| | Cardiovascular Diseases | 2 | 2020 | 493 | 0.190 |
Why?
| | RNA | 1 | 2022 | 169 | 0.180 |
Why?
| | Podocytes | 1 | 2021 | 18 | 0.180 |
Why?
| | Inflammation | 1 | 2025 | 641 | 0.170 |
Why?
| | Diabetic Nephropathies | 1 | 2021 | 61 | 0.170 |
Why?
| | RNA, Fungal | 1 | 2020 | 18 | 0.170 |
Why?
| | RNA, Bacterial | 1 | 2020 | 53 | 0.170 |
Why?
| | Copepoda | 1 | 2019 | 1 | 0.160 |
Why?
| | Glucose | 2 | 2020 | 358 | 0.160 |
Why?
| | Luciferases | 1 | 2019 | 50 | 0.160 |
Why?
| | Metabolic Diseases | 1 | 2020 | 47 | 0.160 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 66 | 0.150 |
Why?
| | Exosomes | 1 | 2019 | 56 | 0.140 |
Why?
| | Recombinant Proteins | 1 | 2019 | 492 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 81 | 0.140 |
Why?
| | Nanoparticles | 1 | 2019 | 127 | 0.140 |
Why?
| | Computational Biology | 1 | 2019 | 209 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2019 | 328 | 0.130 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 222 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 562 | 0.120 |
Why?
| | Antineoplastic Agents | 1 | 2024 | 1214 | 0.120 |
Why?
| | Endothelium, Vascular | 1 | 2014 | 257 | 0.100 |
Why?
| | Cell Line, Tumor | 3 | 2024 | 1418 | 0.100 |
Why?
| | Liver | 1 | 2018 | 1154 | 0.100 |
Why?
| | Humans | 12 | 2025 | 52114 | 0.100 |
Why?
| | Kidney Failure, Chronic | 1 | 2014 | 212 | 0.090 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2014 | 201 | 0.090 |
Why?
| | Lipids | 2 | 2024 | 159 | 0.090 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 96 | 0.080 |
Why?
| | Proteome | 2 | 2021 | 169 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2025 | 1872 | 0.070 |
Why?
| | Mice, Knockout | 2 | 2021 | 893 | 0.070 |
Why?
| | Male | 5 | 2021 | 26652 | 0.070 |
Why?
| | Cattle | 1 | 2025 | 208 | 0.060 |
Why?
| | Albumins | 1 | 2024 | 29 | 0.050 |
Why?
| | Gene Silencing | 1 | 2024 | 120 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2024 | 215 | 0.050 |
Why?
| | Apolipoprotein A-I | 1 | 2022 | 6 | 0.050 |
Why?
| | Phosphatidylcholines | 1 | 2022 | 27 | 0.050 |
Why?
| | Streptozocin | 1 | 2021 | 24 | 0.040 |
Why?
| | Organ Specificity | 1 | 2021 | 116 | 0.040 |
Why?
| | Antirheumatic Agents | 1 | 2020 | 39 | 0.040 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2021 | 137 | 0.040 |
Why?
| | Membranes | 1 | 2019 | 15 | 0.040 |
Why?
| | Secretory Pathway | 1 | 2019 | 4 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2019 | 172 | 0.040 |
Why?
| | Sialyltransferases | 1 | 2019 | 3 | 0.040 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2019 | 3 | 0.040 |
Why?
| | Mice, Nude | 1 | 2019 | 231 | 0.040 |
Why?
| | Nucleic Acids | 1 | 2019 | 14 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2019 | 53 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 2021 | 265 | 0.040 |
Why?
| | Particle Size | 1 | 2019 | 78 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 182 | 0.040 |
Why?
| | Dogs | 1 | 2019 | 182 | 0.040 |
Why?
| | Mediator Complex Subunit 1 | 1 | 2018 | 1 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 221 | 0.040 |
Why?
| | Transcriptome | 1 | 2021 | 363 | 0.040 |
Why?
| | Anticholesteremic Agents | 1 | 2018 | 31 | 0.040 |
Why?
| | Rats, Zucker | 1 | 2018 | 73 | 0.040 |
Why?
| | Glycolysis | 1 | 2018 | 72 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 460 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 231 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2021 | 1135 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 2019 | 162 | 0.030 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2016 | 47 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 925 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 217 | 0.030 |
Why?
| | Proteomics | 1 | 2019 | 325 | 0.030 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 316 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1101 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 1000 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 1665 | 0.030 |
Why?
| | Female | 3 | 2020 | 28055 | 0.030 |
Why?
| | Tennessee | 1 | 2014 | 37 | 0.030 |
Why?
| | Cohort Studies | 1 | 2019 | 1541 | 0.030 |
Why?
| | Chemotaxis | 1 | 2014 | 21 | 0.030 |
Why?
| | Middle Aged | 2 | 2020 | 13028 | 0.030 |
Why?
| | Biological Transport | 1 | 2014 | 150 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2014 | 142 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2014 | 163 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2014 | 102 | 0.030 |
Why?
| | Adult | 2 | 2020 | 14095 | 0.030 |
Why?
| | Rats | 1 | 2018 | 3146 | 0.020 |
Why?
| | Cell Line | 1 | 2014 | 1018 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 1035 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 1568 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 1017 | 0.020 |
Why?
| | Apoptosis | 1 | 2014 | 1117 | 0.020 |
Why?
| | Aged | 1 | 2020 | 10142 | 0.020 |
Why?
| | Infant | 1 | 2014 | 3660 | 0.020 |
Why?
| | Child, Preschool | 1 | 2014 | 4001 | 0.020 |
Why?
| | Risk Factors | 1 | 2014 | 3922 | 0.020 |
Why?
| | Adolescent | 1 | 2014 | 6681 | 0.010 |
Why?
| | Child | 1 | 2014 | 7147 | 0.010 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|